Cytidine

DB02097InvestigationalSmall molecule

Cytidine is a drug used to manage neuropsychiatric deficits associated with cerebrovascular diseases in combination with uridine. A drug used to treat a decline in brain functions caused by various brain disorders.

Chemical structure of Cytidine
Formula / weight
C9H13N3O5 · 243.2166 g/mol (avg)
Also known as
Cytosine riboside

Resolves to

Compound
UNII5CSZ8459RPCAS65-46-3ChEMBLCHEMBL95606ChEBI17562PubChem6175KEGGD07769
Structure
InChIKeyUHDGCWIWMRVCDJ-XVFCMESISA-NSMILESNC1=NC(=O)N(C=C1)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Targets
Q9BZX2UCK2

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
9Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
1ContraindicationEach with its own population and attribute set
Sign in
6Marketed productsAcross 1 country and 1 labeller
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cytidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In